Oxford University to launch study on medical benefits of marijuana

Oxford University is set to launch a £10 million research programme into medical cannabis. They will be investigating the role of cannabis medicines in treating pain, cancer and inflammatory diseases. The programme is being financially backed by private equity firm Kingsley Capital Partners, who invested the money in the hope of creating an international hub for cannabinoid research.
Oxford University is set to launch a £10 million research programme into medical cannabis. They will be investigating the role of cannabis medicines in treating pain, cancer and inflammatory diseases. The programme is being financially backed by private equity firm Kingsley Capital Partners, who invested the money in the hope of creating an international hub for cannabinoid research.

Source Voltface

Setting the main stream media record straight

The main stream media coverage of Oxford Universities new research effort to understand the complex Cannabis plant has at times seemed uninformed. The CTA UK considers that this new research project is just the first in a fantastic opportunity for the UK to catch up with the rest of the world. 

The Cannabis Trades Association was formed when a number of ethical companies producing and supplying Cannabidiol (CBD, a cannabinoid from cannabis) based products responded to the MHRA statement of intent to classify CBD as a medicine.
The Association has had a number of discussions since and is in the process of clarifying the status of wellbeing and medicinal CBD dosage with the MHRA. The CTA UK is a new and professional organisation advocating a new post Brexit approach to Cannabis based on the current world leading research. The Association believes that a focused approach based on three important strands of understanding will lead to a more nuanced and rational approach to cannabis and cannabinoids in the UK.

Science and Factual analysis.

There are a great many research projects taking place all over the world we are in the process of understanding and correlating this information. We aim to work with other stake holders developing a reasoned and well informed road map for Cannabis research and development in the UK.
The UK government currently recognises 97 compounds in Cannabis, more advanced research countries put the number far higher. The UK government controls 12 of these due to their psychoactive nature. (See attached pdf)
The CTA UK is working with government and industry to ensure a legal and regulated Cannabis industry grows from these small beginnings. The rest of the world is waking up to the beneficial potential of “Cannabis 2.0” and the UK needs to catch up.

Experiential Evidence gathering

The advent of big data now allows us to gather the stories of real people in real situations. Groups such as CBD Users UK on Facebook report evidence of real wellbeing benefits through the use of legal Cannabinoids. The CTA UK is working with such groups to explore the big data being produced and is talking with governing bodies and researchers to establish best practice and codes of conduct in this burgeoning industry.
The fact that many people are recounting their stories even with the threat of legal action shows the need to understand more and judge less.

Opportunity development

There are a large number of benefits in realising Cannabis offers real opportunity for enabling better societies. The development of hemp (a form of Cannabis) based economy offers so many societal benefits that we are only just starting to appreciate in terms of ecology and sustainable development to mention just two.
The potential for wellbeing and medicinal cannabinoids to produce a tangible change in the way we view our bodies and the world is just too much of an opportunity for the UK to miss out on. The key here is regulated development based on factual analysis and societal benefit. The Government and industry have to work together to enable a step change in the way we view cannabis.

Licensing & The Forthcoming Regulation

CTA UK approved

[et_pb_section admin_label=”section”][et_pb_row admin_label=”row”][et_pb_column type=”4_4″][et_pb_text admin_label=”Text” background_layout=”light” text_orientation=”left” use_border_color=”off” border_color=”#ffffff” border_style=”solid”]

Licensing & The Forthcoming Regulation & What It Means To You.

Firstly, don’t panic!
There is not going to be a requirement to rush out and go get a licence to sell CBD products (even if it were that simple!). We think you are likely going to be required to register as a seller, something you can do quickly, easily and cheaply on the CannabisTrades website for the princely sum of £10 per annum. You don’t even have to become a member.
Secondly…why do you think you are going to require this licence?

If you think you are going to market a product that is going to make medical claims without being able to back up these claims, then think again…a Marketing Authority allows you to market your products as a medicine…that’s an authority for each condition you wish to claim about, which is a whole set of human trials performed by qualified staff in hospitals and universities…Sativex cost £103 million to get its initial authority…and 95% of medicines simply don’t make it through. At all.
Lastly, do you have a product that you believe is stronger than most of the others on the market? Well then there’s the final route of a THR or Traditional Herbal Registration, this last option allows you to make generalised claims about a group of related conditions without the expense of trials based on known and documented use over a number of years, you still have to ensure your product is safe and suitable, but overall you could get a product registered that way, it’s going to cost you around £10k all in…probably.
So the question is why do you need to bother?

For the majority of sellers they agree that they sell a food supplement, it may have a pharmacological effect, but it simply isn’t a defined enough effect to be used for any identifiable condition, therefore is a general remedy, something you take every day to ward off a cold etc. much like a vitamin…
So our advice is to take advice, the Cannabis Trades Association has a legal team that comprises of one of the largest legal firms that specialise in the food and drugs sector in the UK as well as representing the majority of the CBD industry, we grow every day and we work for the members to ensure that they get the very best, most up to date advice available…and we talk to the various government departments regularly. Can you get hold of them?

We hope this clears up any confusion and ask you to get in touch if there’s anything else you require.

[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]

This entry was posted in News and tagged . Bookmark the permalink.

CTAUK works with the BBFC to unblock member sites

[et_pb_section admin_label=”section”][et_pb_row admin_label=”row”][et_pb_column type=”4_4″][et_pb_text admin_label=”Text” background_layout=”light” text_orientation=”left” use_border_color=”off” border_color=”#ffffff” border_style=”solid”]

The British Board of Film Classification (BBFC) is the principle “assesor” for UK media.

In July 2013 the BBFC took over from the Independent Mobile Classification Board in providing the framework for mobile operators to apply filter classification.

A number of member sites where being blocked on mobile devices because of the mention of Cannabis.
The CTAUK has successful Challenged this and won a decision.

“We found no content which overtly glamorised the recreational use of cannabis or encouraged illegal activity. In addition, in relation to the MHRA’s public statement on products containing Cannabidiol (CBD), Love CBD was not marketing its products as a medicine, or claiming any medical benefits for them, but as food supplements. Therefore, we found no content which we would classify 18 or refuse to classify. We will now inform the Mobile Network Operators of our decision.”

[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]